tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

NBIX Stock Latest News

NBIX Earnings this Week: How Will it Perform?
Pre-EarningsNBIX Earnings this Week: How Will it Perform?
22h ago
NBIX
Neurocrine initiates Phase 3 registrational program for NBI-1117568
PremiumThe Fly
Neurocrine initiates Phase 3 registrational program for NBI-1117568
4d ago
NBIX
Neurocrine price target lowered to $158 from $163 at Canaccord
PremiumThe Fly
Neurocrine price target lowered to $158 from $163 at Canaccord
6d ago
NBIX
Strong Market Positioning and Growth Potential for Neurocrine’s Ingrezza Amidst Short-term Challenges
PremiumRatings
Strong Market Positioning and Growth Potential for Neurocrine’s Ingrezza Amidst Short-term Challenges
6d ago
NBIX
Neurocrine announces publication of a post-hoc analysis of Ingrezza
PremiumThe Fly
Neurocrine announces publication of a post-hoc analysis of Ingrezza
9d ago
NBIX
Optimistic Buy Rating for Neurocrine Due to Crenessity’s Potential in CAH Treatment
PremiumRatingsOptimistic Buy Rating for Neurocrine Due to Crenessity’s Potential in CAH Treatment
12d ago
NBIX
Neurocrine price target lowered to $168 from $185 at H.C. Wainwright
Premium
The Fly
Neurocrine price target lowered to $168 from $185 at H.C. Wainwright
12d ago
NBIX
PepsiCo, Hormel, Neurocrine, Exelon, Aurora: Trending by Analysts
Premium
Weekend Updates
PepsiCo, Hormel, Neurocrine, Exelon, Aurora: Trending by Analysts
15d ago
AUR
EXC
Nike initiated, GM downgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nike initiated, GM downgraded: Wall Street’s top analyst calls
19d ago
DD
GM
Needham upgrades Neurocrine on positive Crenessity survey
PremiumThe Fly
Needham upgrades Neurocrine on positive Crenessity survey
19d ago
NBIX
Neurocrine upgraded to Buy from Hold at Needham
PremiumThe Fly
Neurocrine upgraded to Buy from Hold at Needham
19d ago
NBIX
Neurocrine upgraded to Outperform at RBC Capital following pullback
PremiumThe Fly
Neurocrine upgraded to Outperform at RBC Capital following pullback
20d ago
NBIX
Neurocrine upgraded to Outperform from Sector Perform at RBC Capital
PremiumThe FlyNeurocrine upgraded to Outperform from Sector Perform at RBC Capital
20d ago
NBIX
Neurocrine price target lowered to $155 from $163 at Guggenheim
Premium
The Fly
Neurocrine price target lowered to $155 from $163 at Guggenheim
24d ago
NBIX
Neurocrine Biosciences Appoints Dr. Keswani as CMO
Premium
Company Announcements
Neurocrine Biosciences Appoints Dr. Keswani as CMO
30d ago
8K
NBIX
Neurocrine names Dr. Sanjay Keswani as Chief Medical Officer
PremiumThe Fly
Neurocrine names Dr. Sanjay Keswani as Chief Medical Officer
30d ago
NBIX
Neurocrine price target lowered to $137 from $154 at UBS
PremiumThe Fly
Neurocrine price target lowered to $137 from $154 at UBS
30d ago
NBIX
Neurocrine’s Strong Market Position and Growth Potential Justify Buy Rating Amid Challenges
PremiumRatings
Neurocrine’s Strong Market Position and Growth Potential Justify Buy Rating Amid Challenges
30d ago
NBIX
Neurocrine price target raised to $184 from $183 at JPMorgan
PremiumThe Fly
Neurocrine price target raised to $184 from $183 at JPMorgan
1M ago
NBIX
Neurocrine’s ingrezza shows efficacy in tardive dyskinesia study
PremiumThe FlyNeurocrine’s ingrezza shows efficacy in tardive dyskinesia study
1M ago
NBIX
Neurocrine presents new KINECT-HD data
Premium
The Fly
Neurocrine presents new KINECT-HD data
2M ago
NBIX
Neurocrine price target lowered to $139 from $148 at RBC Capital
Premium
The Fly
Neurocrine price target lowered to $139 from $148 at RBC Capital
2M ago
NBIX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >